You are here

Adipose Clinical Trials

Condition:   Ischemic Congestive Heart Failure
Intervention:   Procedure: Fat Harvesting and Implantation of Adipose Derived Stem Cells
Sponsors:   Ageless Regenerative Institute;   Instituto de Medicina Regenerativa, S.A. de C.V.
Withdrawn - verified July 2017
Condition:   Frailty Syndrome
Intervention:   Procedure: Harvesting and implantation of stem cells
Sponsors:   Ageless Regenerative Institute;   Instituto de Medicina Regenerativa, S.A. de C.V.
Recruiting - verified July 2017
Condition:   Crohn
Intervention:   Biological: Allogenic human adipose-derived stem cells
Sponsor:   Anterogen Co., Ltd.
Unknown status - verified September 2011
Conditions:   Complex Perianal Fistula;   Crohn Disease
Interventions:   Drug: Expanded autologous adipose-derived adult stem cells (eASCs);   Drug: Placebo
Sponsor:   Cellerix
Terminated - verified June 2011
Condition:   Complex Perianal Fistula
Interventions:   Biological: Autologous cultured adipose derived stem cells(low dose group);   Biological: Autologous cultured adipose derived stem cells(high dose group)
Sponsor:   Anterogen Co., Ltd.
Terminated - verified March 2011
Condition:   Degenerative Arthritis
Intervention:   Procedure: Autologous Adipose Tissue derived MSCs Transplantation
Sponsor:   Biostar
Completed - verified March 2014
Condition:   Buerger's Disease
Intervention:   Biological: RNL-Vascostem®
Sponsor:   Biostar
Completed - verified March 2014
Condition:   Spinal Cord Injury
Intervention:   Other: Autologous Adipose Derived Mesenchymal Stem Cells
Sponsor:   Biostar
Completed - verified March 2014
Conditions:   Critical Limb Ischemia (CLI);   Diabetes
Intervention:   Drug: Autologous adipose derived mesenchymal stem cells
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas
Completed - verified November 2014
Conditions:   Graft Versus Host Disease;   Chronic and Expanded Graft Versus Host Disease;   Immune System Diseases
Interventions:   Other: Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.;   Other: Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas
Completed - verified November 2016

Pages